# PRODA BIOTECH, LLC: Development of a new combination therapy for pancreatic ductal adenocarcinoma treatment

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | PRODA BIOTECH, LLC |
| Location | MARIETTA, GA |
| Project | Development of a new combination therapy for pancreatic ductal adenocarcinoma treatment |
| Project number | 1R44CA314813-01 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $1,139,113 |
| Awarded | 2026-09-04 |
| Project period | 2026-09-04 to 2028-03-31 |
| UEI | KMRLL3EPWVK5 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409793). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.